Cerys Pharmaceuticals Private Limited, a active private limited company, was established on 25 June 2020 in Sion, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999MH2020PTC340993. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹3.30 M.
Employing 24 professional, Its leadership includes Vikram Bhadoriya (Director), Devendra Tiwari (Director), Amit Sharma (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4Th Floor Grd Plot-224, 29,Bmc Tenement Mukundrao Ambedkar Road Gaikawad Nagar, Sion, Maharashtra, 400022.
U74999MH2020PTC340993
340993
25 June 2020
₹3.50 M
₹3.30 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Cerys Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikram Bhadoriya | Director | 10 Feb 2022 | Current |
| Devendra Tiwari | Director | 24 Apr 2021 | Current |
| Amit Sharma | Director | 25 Jun 2020 | Current |
| Anurudra Mukherjee | Director | 25 Jun 2020 | Current |
| Raja Ramasamy | Director | 25 Jun 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cerys Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.17% increase. The company also saw a substantial fall in profitability, with a 76.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 141.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Cerys Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Cerys Pharmaceuticals has a workforce of 24 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cerys Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cerys Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cerys Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Cerys Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Vikram Bhadoriya was appointed as a Director was appointed as a Director on 10 Feb 2022 & has been associated with this company since 3 years 9 months . was completed.
Progress on Devendra Tiwari was appointed as a Director was appointed as a Director on 24 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
Amit Sharma was appointed as a Director was appointed as a Director on 25 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
The activity Anurudra Mukherjee was appointed as a Director was appointed as a Director on 25 Jun 2020 & has been associated with this company since 5 years 5 months . was completed.
The CIN of Cerys Pharmaceuticals Private Limited is U74999MH2020PTC340993.
Cerys Pharmaceuticals Private Limited is headquartered at 4Th Floor Grd Plot-224, 29,Bmc Tenement Mukundrao Ambedkar Road Gaikawad Nagar, Sion, Maharashtra, 400022.
Cerys Pharmaceuticals Private Limited was incorporated on 25 June 2020.
The current directors of Cerys Pharmaceuticals Private Limited are
The primary industry of Cerys Pharmaceuticals Private Limited is Trade.
Cerys Pharmaceuticals Private Limited is unlisted.
The authorized capital of Cerys Pharmaceuticals Private Limited is ₹3.50 M, and the paid-up capital is ₹3.30 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX